Literature DB >> 17285094

Treatment characteristics and illness burden among European Americans, African Americans, and Latinos in the first 2,000 patients of the systematic treatment enhancement program for bipolar disorder.

Jodi M Gonzalez1, Peter Thompson, Michael Escamilla, Mako Araga, Vivek Singh, Niamh Farrelly, Michael E Thase, David J Miklowitz, Charles L Bowden.   

Abstract

OBJECTIVE: Across ethnicity/race, prevalence rates of bipolar disorder are similar. However, African Americans and Latinos may receive less specialty mental health treatment and different medications, and may be less adherent to treatment regimens than European American patients. This study compared illness characteristics, treatment history, and overall functioning in a sample of European American, African American, and Latino patients with bipolar disorder.
METHODS: The samples were drawn from the first 2,000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder. There were 1,686 European Americans, 65 African Americans, and 77 Latinos. The data were collected upon study entry, with structured interviews, clinicianrated forms, and self report.
RESULTS: African Americans had a greater likelihood of psychosis and fewer psychiatric medication prescriptions than did European Americans. Latinos had greater alcohol comorbidity, fewer psychiatric medication prescriptions and specialty treatment visits, and more frequent religious service attendance than did European Americans. Depression and manic episode severity and functional outcomes were similar across groups.
CONCLUSIONS: Patients with bipolar disorder who are members of ethnic/racial minority groups continue to receive less intensive specialized mental health treatment than do European American patients. These findings may be related to provider, patient, or provider-patient relationship variables. Despite treatment differences and greater comorbidity and sympomatology, there were no differences among the three groups in overall functioning, suggesting additional outcome measurement is warranted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17285094

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  6 in total

1.  One-year treatment outcomes of African-American and Hispanic patients with bipolar I or II disorder in STEP-BD.

Authors:  Jodi M Gonzalez; Charles L Bowden; Nancy Berman; Ellen Frank; Mark S Bauer; Jane N Kogan; Margarita Alegría; David J Miklowitz
Journal:  Psychiatr Serv       Date:  2010-02       Impact factor: 3.084

2.  Longitudinal racial/ethnic disparities in antimanic medication use in bipolar-I disorder.

Authors:  Alisa B Busch; Haiden A Huskamp; Brian Neelon; Tim Manning; Sharon-Lise T Normand; Thomas G McGuire
Journal:  Med Care       Date:  2009-12       Impact factor: 2.983

3.  Disparities in Treatment and Service Utilization Among Hispanics and Non-Hispanic Whites with Bipolar Disorder.

Authors:  Stephanie Salcedo; Kaja J McMaster; Sheri L Johnson
Journal:  J Racial Ethn Health Disparities       Date:  2016-04-29

4.  Bipolar-I patient characteristics associated with differences in antimanic medication prescribing.

Authors:  Alisa B Busch; Richard G Frank; Gary Sachs; Sharon-Lise T Normand
Journal:  Psychopharmacol Bull       Date:  2009

5.  Enhancing outcomes in patients with bipolar disorder: results from the Bipolar Disorder Center for Pennsylvanians Study.

Authors:  Andrea Fagiolini; Ellen Frank; David A Axelson; Boris Birmaher; Yu Cheng; David E Curet; Edward S Friedman; Ariel G Gildengers; Tina Goldstein; Victoria J Grochocinski; Patricia R Houck; Mary G Stofko; Michael E Thase; Wesley K Thompson; Scott R Turkin; David J Kupfer
Journal:  Bipolar Disord       Date:  2009-06       Impact factor: 6.744

6.  Bipolar disorder center for Pennsylvanians: implementing an effectiveness trial to improve treatment for at-risk patients.

Authors:  David J Kupfer; David A Axelson; Boris Birmaher; Charlotte Brown; David E Curet; Andrea Fagiolini; Ellen Frank; Edward S Friedman; Victoria J Grochocinski; Patricia R Houck; Amy M Kilbourne; Benoit H Mulsant; Bruce G Pollock; Charles F Reynolds; Mary G Stofko; Holly A Swartz; Michael E Thase; Scott R Turkin; Ellen M Whyte
Journal:  Psychiatr Serv       Date:  2009-07       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.